Alembic Pharmaceuticals gains on raising Rs 150 crore via NCDs

19 Mar 2019 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 542.00, up by 2.85 points or 0.53% from its previous closing of Rs. 539.15 on the BSE.

The scrip opened at Rs. 542.60 and has touched a high and low of Rs. 546.00 and Rs. 541.00 respectively. So far 558 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 664.00 on 27-Sep-2018 and a 52 week low of Rs. 412.40 on 24-May-2018.

Last one week high and low of the scrip stood at Rs. 554.00 and Rs. 537.55 respectively. The current market cap of the company is Rs. 10218.51 crore.

The promoters holding in the company stood at 72.96%, while Institutions and Non-Institutions held 15.05% and 11.99% respectively.

Alembic Pharmaceuticals has raised Rs 150 crore through allotted of 1,500 at 8.37% Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of Rs 10 lakh per NCD under Tranche III. The NCD Committee of the Company at its meeting held on March 19, 2019 has allotted the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

886.15 -0.40 (-0.05%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×